Cytological analysis of small branch-duct intraductal papillary mucinous neoplasms provides a more accurate risk assessment of malignancy than symptoms
|Published in||CytoJournal. 2011, vol. 8, p. 21|
|Abstract||The Sendai guidelines for management of patients with clinically suspected intraductal papillary mucinous neoplasms (IPMN) recommend resection of cysts > 30 mm, a dilated main pancreatic duct (MPD) > 6 mm, a mural nodule (MN), symptoms or positive cytology. Although sensitive, asymptomatic cysts, nonspecific symptoms, and a high threshold for positive cytology limit the specificity of the guidelines. We have assessed the value of cytology relative to symptom for predicting malignancy in IPMNs without high-risk imaging features.|
This document has no fulltext available yet, but you can contact its author by using the form below.
|Research group||Métastases du foie (657)|
|ONO, Jill et al. Cytological analysis of small branch-duct intraductal papillary mucinous neoplasms provides a more accurate risk assessment of malignancy than symptoms. In: CytoJournal, 2011, vol. 8, p. 21. https://archive-ouverte.unige.ch/unige:25667|